An 8-week randomized double-blind trial comparing GHK-Cu in nano-lipid carrier against Matrixyl 3000 showed 55.8% reduction in wrinkle volume versus control and 31.6% reduction versus the active comparator
It has not received approval from Health Canada for therapeutic use, meaning it cannot be prescribed or marketed as a treatment
In 2026, 5-Amino-1MQ research continues to expand, particularly into its long-term effects on metabolic health, cellular aging, and potential applications in neurodegenerative studies
Your expert provider connects an IV drip to a vein in your arm, and then we can infuse critical fluids, electrolytes, vitamins, minerals, and more
A short non-diabetic cohort measured a flat 2.5 mg dose for about four weeks and found weight and insulin-resistance movement (about -4.7% body weight). That makes "2.5 mg has no data" outdated
Shipping is fast and overall the process is easy